SubHero Banner
Text

Moderna COVID-19 vaccine – FDA advisors discuss emergency use authorization request for 6 - 17 years of age

June 14, 2022 - The Food and Drug Administration (FDA) convened a Vaccine and Biologic Products Advisory Committee (VRBPAC) to discuss an Emergency Use Authorization (EUA) for Moderna’s vaccine to prevent COVID-19 in individuals 6 – 17 years of age.

Download PDF